Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-29 Purchase |
2022-10-03 4:42 pm |
Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director |
16,932 | $6.2577 | $105,955 | 24,932 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-06 5:02 pm |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
2,208 | $3.4669 | $7,655 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-10-06 Option Award |
2022-10-11 4:39 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
78,500 | $0 | 78,500 (Direct) |
View |
| 2022-10-06 Option Award |
2022-10-11 4:38 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
78,500 | $0 | 78,500 (Direct) |
View |
| 2022-10-06 Option Award |
2022-10-11 4:38 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
87,500 | $0 | 87,500 (Direct) |
View |
| 2022-10-06 Option Award |
2022-10-11 4:37 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
87,500 | $0 | 87,500 (Direct) |
View |
| 2022-10-06 Option Award |
2022-10-11 4:36 pm |
N/A 2032-10-05 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
195,250 | $0 | 195,250 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:16 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:15 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:14 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | TYSON TIMOTHY Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:14 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | OH ANDREW M. Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:13 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:09 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:08 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:08 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-19 5:07 pm |
N/A 2032-09-15 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:10 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Dunsire Deborah Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:10 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | AKKARAJU SRINIVAS Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:09 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Young Richard A Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:09 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | WIRTH PETER Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:08 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | SHARP PHILLIP A Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:08 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:07 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Fanucci Marsha Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:07 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Eckhardt Sue Gail Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:06 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Alles Mark J Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-04-04 5:04 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
14,115 | $1.12 | 30,885 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-04-04 5:03 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
27,281 | $1.12 | 59,719 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-04-04 5:02 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
27,266 | $1.12 | 59,734 (Direct) |
View |
| 2022-04-01 Tax Withholding |
2022-04-04 5:02 pm |
N/A N/A |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
58,883 | $1.12 | 692,723 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:10 pm |
N/A 2032-02-14 |
Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer |
405,000 | $0 | 405,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:09 pm |
N/A 2032-02-14 |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:08 pm |
N/A 2032-02-14 |
Syros Pharmaceuticals Inc. | SYRS | Stephens Kristin Chief Development Officer |
380,000 | $0 | 380,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:08 pm |
N/A 2032-02-14 |
Syros Pharmaceuticals Inc. | SYRS | Olson Eric R Chief Scientific Officer |
380,000 | $0 | 380,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:07 pm |
N/A 2032-02-14 |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
205,000 | $0 | 205,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 4:05 pm |
N/A 2032-02-14 |
Syros Pharmaceuticals Inc. | SYRS | Simonian Nancy A President & CEO |
1,015,000 | $0 | 1,015,000 (Direct) |
View |
| 2021-10-12 Option Award |
2021-10-13 4:06 pm |
N/A 2031-10-11 |
Syros Pharmaceuticals Inc. | SYRS | Haas Jason Chief Financial Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2021-09-27 Option Award |
2021-09-28 4:24 pm |
N/A 2031-09-26 |
Syros Pharmaceuticals Inc. | SYRS | Chee Conley Chief Commercial Officer |
360,000 | $0 | 360,000 (Direct) |
View |